Nemonoxacin Malate

苹果酸奈诺沙星

Report date: 2026/03/04 20:01:44
NMEQIDP

Base Information

Drug NameNemonoxacin Malate
Drug Alias Name奈莫沙星Nemonoxacin malate sodium chloridenemonoxacinonemonoxacinumNenofloxacin +[9] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsCommunity Acquired PneumoniaLiver DysfunctionDiabetic Foot +[7] 
Global Approved IndicationsCommunity Acquired PneumoniaBacterial Infections
Approved Indications in ChinaCommunity Acquired Pneumonia
Original Approved Country/TerritoryTaiwan
Original Approved Date2014/03/12
Country/TerritoryUnited StatesTaiwanThailand +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaiGen Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesProductos Científicos S. A. De C. V.YSP Industries (M) Sdn BhdTaiGen Biotechnology Co Ltd +[9] 
Inactive CompaniesZhejiang Medicine Co Ltd
Active IndicationsCommunity Acquired PneumoniaUrinary Tract InfectionsBacterial Infections
Inactive IndicationsLiver DysfunctionDiabetic FootRenal Insufficiency +[4] 

Other Information

ATC CodeJ01MB08
Related LinksWikipediaDrugBankKEGG